1. Aladağ E, Kelkitli E, Göker H. Acute Graft-Versus-Host Disease: A Brief Review. Turk J Haematol. 2020;37:1–4.
2. Penack O, Marchetti M, Ruutu T, Aljurf M, Bacigalupo A, Bonifazi F, et al. Prophylaxis and management of graft versus host disease after stem-cell transplantation for haematological malignancies: updated consensus recommendations of the European Society for Blood and Marrow Transplantation. Lancet Haematol. 2020;7:e157–e67.
3. Zeiser R, Blazar BR, Acute Graft-versus-Host Disease -. Biologic Process, Prevention, and Therapy. N Engl J Med. 2017;377:2167–79.
4. Stem Cell Application Group CSoHCMA. Chinese consensus of allogeneic hematopoietic stem cell transplantation for hematological disease (III) -acute graft-versus-host disease (2020). Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi. 2020;41:529–36.
5. Phelan R, Arora M, Chen M. Current use and outcome of hematopoietic stem cell transplantation: CIBMTR summary slides. 2020. Accessed at https://www.cibmtr.org/ReferenceCenter/SlidesReports/SummarySlides/pages/index.aspx.